Form 4 for HTFL Heartflow, Inc.
Accepted 2026-04-03 18:15:31 ET · period of report 2026-04-01 · accession 0001464521-26-000052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-03 18:15 | 2026-04-01 | HTFL | Rogers Campbell | Chief Medical Off | M - OptEx | $2.25 | +67.0K | 145.5K | +85% | +$150.6K |
| DT | 2026-04-03 18:15 | 2026-04-01 | HTFL | Rogers Campbell | Chief Medical Off | S - Sale+OE | $24.64 | -64.5K | 81.0K | -44% | -$1.59M |
| DMT | 2026-04-03 18:15 | 2026-04-01 | HTFL | Rogers Campbell | Chief Medical Off | M - OptEx | $0.00 | -67.0K | 81.6K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-01 | M | A | 291 | $8.33 | 78,809 | D | — | — | (F1) The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. |
| 2 | Common | Common Stock | 2026-04-01 | M | A | 19,111 | $2.22 | 97,920 | D | — | — | (F1) The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. |
| 3 | Common | Common Stock | 2026-04-01 | M | A | 40,766 | $2.22 | 138,686 | D | — | — | (F2) The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. |
| 4 | Common | Common Stock | 2026-04-01 | M | A | 6,849 | $2.22 | 145,535 | D | — | — | (F2) The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. |
| 5 | Common | Common Stock | 2026-04-01 | S | D | 64,533 | $24.64 | 81,002 | D | — | — | (F3) Includes the sale of 16,918 shares of common stock held and the option exercise and sale of 47,615 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. (F4) This transaction was executed in multiple trades at price ranging from $24.03 to $25.27. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Derivative | Stock Options | 2026-04-01 | M | D | 6,849 | $0.00 | 0 | D | $2.22 · — to 2033-07-10 | 6,849 Common Stock | (F2) The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. (F5) These stock options are fully exercisable. |
| 7 | Derivative | Stock Option | 2026-04-01 | M | D | 291 | $0.00 | 3,298 | D | $8.33 · — to 2031-04-12 | 291 Common Stock | (F1) The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. (F5) These stock options are fully exercisable. |
| 8 | Derivative | Stock Option | 2026-04-01 | M | D | 19,111 | $0.00 | 122,399 | D | $2.22 · — to 2033-07-10 | 19,111 Common Stock | (F1) The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. (F6) The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date. |
| 9 | Derivative | Stock Option | 2026-04-01 | M | D | 40,766 | $0.00 | 81,633 | D | $2.22 · — to 2033-07-10 | 40,766 Common Stock | (F2) The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025. (F6) The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date. |